Hudson Bay Capital Management
PYXS icon

Hudson Bay Capital Management’s Pyxis Oncology PYXS Stock Holding History

Hudson Bay Capital Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,790
Closed -$15.2K – 1599
2025
Q2 		$15.2K Buy
+13,790
New +$15.5K ﹤0.01% 1323

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hudson Bay Capital Management's PYXS Position: Q3 2025 in Review

Hudson Bay Capital Management sold out of Pyxis Oncology (PYXS) in Q3 2025, closing a stake of 13,790 shares — an estimated $15.2K sold.

Hudson Bay Capital Management first reported a position in PYXS in Q2 2025 and held it in 1 quarter. The position peaked at $15.2K in Q2 2025. 73 funds tracked by Wall St. Rank hold PYXS as of Q3 2025.

  • Hudson Bay Capital Management reported no remaining Pyxis Oncology position as of Q3 2025 after selling out during the quarter.
  • Hudson Bay Capital Management sold 13,790 Pyxis Oncology shares in Q3 2025, an estimated $15.2K.
  • Hudson Bay Capital Management first reported a position in Pyxis Oncology in Q2 2025 and held it in 1 quarter.
  • Hudson Bay Capital Management's Pyxis Oncology position peaked at $15.2K in Q2 2025.
  • 73 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2025.

Based on Hudson Bay Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.